Checkpoint Therapeutics' Shares Rise After Securing First FDA Approval

WSJ12/14 08:09

Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT (Cosibelimab-ipdl)

GlobeNewswire12/14 07:15

Trading Halt: Halted at 5:26:59 P.m. ET - Trading Halt: Halt News Pending

Benzinga12/14 06:27

FDA Decision On Checkpoint Therapeutics' Cosibelimab Due On Dec.28 - Will Second Time Be The Charm?

RTTNews12/12 17:17

Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend

PR Newswire12/02 23:18

Checkpoint Therapeutics Analyst Ratings

Benzinga11/15 02:25